Mesenteric Venous Thrombosis Overview
Learn About Mesenteric Venous Thrombosis
Mesenteric venous thrombosis (MVT) is a blood clot in one or more of the major veins that drain blood from the intestine. The superior mesenteric vein is most commonly involved.
MVT
MVT is a clot that blocks blood flow in a mesenteric vein. There are two such veins through which blood leaves the intestine. The condition stops the normal blood circulation of the intestine and can result in damage to the intestine.
The exact cause of MVT is unknown. However, there are many diseases that can lead to MVT. Many of the diseases cause swelling (inflammation) of the tissues surrounding the veins, and include:
- Appendicitis
- Cancer of the abdomen
- Diverticulitis
- Liver disease with cirrhosis
- High blood pressure in the blood vessels of the liver
- Abdominal surgery or trauma
- Pancreatitis
- Inflammatory bowel disorders (Crohn disease and ulcerative colitis)
- Heart failure
People who have disorders that make the blood more likely to stick together (clot) have a higher risk for MVT and include:
- Protein C or S deficiencies
- Polycythemia vera
- Essential thrombocythemia
Birth control pills and estrogen medicines also increase risk.
MVT is more common in men than women. It mainly affects middle aged or older adults.
Symptoms may include any of the following:
- Abdominal pain, which may get worse after eating and over time
- Bloating
- Constipation
- Bloody diarrhea
- Fever
- Septic shock
- Lower gastrointestinal bleeding
- Vomiting and nausea
Blood thinners are used to treat MVT when there is no associated bleeding. In some cases, medicine can be delivered directly into the clot to dissolve it. This procedure is called thrombolysis.
Less often, the clot is removed with a type of surgery called thrombectomy.
If there are signs and symptoms of a severe infection called peritonitis, surgery to remove the injured part of the intestine is done. After surgery, an ileostomy (opening from the small intestine into a bag on the skin) or colostomy (an opening from the colon into the skin) may be needed.
University Of Vermont Medical Center Inc
Mary Cushman is a Hematologist and an Oncologist in Burlington, Vermont. Dr. Cushman is rated as an Elite provider by MediFind in the treatment of Mesenteric Venous Thrombosis. Her top areas of expertise are Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Deep Vein Thrombosis, Embolectomy, and Hormone Replacement Therapy (HRT). Dr. Cushman is currently accepting new patients.
University Of Vermont Medical Center Inc
Neil Zakai is a Hematologist Oncology specialist and a Hematologist in Burlington, Vermont. Dr. Zakai is rated as an Elite provider by MediFind in the treatment of Mesenteric Venous Thrombosis. His top areas of expertise are Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Folate-Deficiency Anemia, Folate Deficiency, and Bone Marrow Aspiration. Dr. Zakai is currently accepting new patients.
Ursula Erfurth-Schmidt practices in Vienna, Austria. Ms. Erfurth-Schmidt is rated as an Elite expert by MediFind in the treatment of Mesenteric Venous Thrombosis. Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Cataract Removal.
The outlook depends on the cause of the thrombosis and any damage to the intestine. Getting treatment for the cause before the intestine has died can result in a good recovery.
Intestinal ischemia is a serious complication of MVT. Part or all of the intestine dies because of poor blood supply.
Contact your health care provider if you have severe or repeated episodes of abdominal pain.
Background: \- To understand diseases of the retina and the eye, information is needed about people with and without such diseases. Researchers want to study these people and follow them over time. They also want to study body tissues and blood to understand the nature of eye disease. Studying genes, cells, and tissues may help them understand why some people get eye problems and others do not, or why some pe...
Summary: The Farseeing Study will explore long-term effectiveness, safety, and treatment patterns among patients being treated with faricimab in real-world, routine clinical practice in China. It is a primary data collection, non-interventional, prospective and retrospective, multi-center study designed to collect real-world, long-term data to gain clinical evidence on faricimab, by observing cohorts of pa...
Published Date: June 17, 2024
Published By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Cloud A, Dussel JN, Webster-Lake C, Indes J. Mesenteric ischemia. In: Yeo CJ, ed. Shackelford's Surgery of the Alimentary Tract. 8th ed. Philadelphia, PA: Elsevier; 2019:chap 87.
Feuerstadt P, Brandt LJ. Intestinal ischemia. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 11th ed. Philadelphia, PA: Elsevier; 2021:chap 118.
Roline CE, Reardon RF. Small intestine. In: Walls RM, ed. Rosen's Emergency Medicine: Concepts and Clinical Practice. 10th ed. Philadelphia, PA: Elsevier; 2023:chap 78.
Schafer AI. Approach to the patient with bleeding or thrombosis. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 157.
